Mar 29, 2020 / 09:00PM GMT
Ryan Weispfenning - Medtronic plc - VP of IR
Okay. We're going to get started, everyone. Good afternoon. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thanks for joining us for our Virtual Cardiac and Vascular Group Investor Briefing to discuss the clinical data that is being released in connection with the 2020 American College of Cardiology together with the World Congress of Cardiology Scientific Sessions. We're pleased that we're able to hold this event, albeit virtually today. While we're not together in Chicago as originally planned, I do hope everyone is staying safe, and our thoughts go out to those that have been affected by the coronavirus.
Before we get started, I want to note that we could make some comments that may be considered forward-looking statements, and actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC, and we do not undertake to
Medtronic PLC CVG Virtual Investor and Analyst Briefing Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
